According to a new report published by K D Market Insights, titled, “Blood Group Typing Market Insights, Trends, Opportunity & Forecast, 2023–2032,” the global blood group typing market size is anticipated to witness steady growth during the forecast period i.e., 2023-2032. The increasing demand for blood transfusions, rising prevalence of chronic diseases requiring regular blood typing, and the importance of accurate blood typing in medical procedures are the major factors augmenting the growth of the global blood group typing market.
Factors such as the increasing demand for blood transfusions and the rising prevalence of chronic diseases contribute to the need for accurate blood typing methods are further expected to create ample growth opportunities for the global blood group typing market during the forecast period i.e., 2023-2032. Moreover, the increasing demand for blood group typing in prenatal testing are expected to contribute towards the market growth during the period.
The North America region accounted for the largest share in the global blood group typing market in 2022. The region is further projected to continue dominating in the market during the forecast period. Primarily driven by the United States. The region's significant demand for blood transfusions, higher adoption of automated blood typing instruments, and favorable reimbursement policies contribute to its market dominance.
According to end user, the hospitals and clinics segment accounted for the largest market share in the blood group typing market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
The global blood group typing market is segmented into product type, technique, test type, end-users and region. Based on product type, the market is bifurcated into instruments, consumables, services. Based on technique, it is classified into PCR-based and microarray techniques, assay-based techniques, massively parallel sequencing techniques, other techniques. Based on test type, it is classified into antibody screening, HLA typing, cross-matching tests, abo blood tests, antigen typing. Based on end user, it is classified into hospitals and clinics, blood banks, diagnostic laboratories, other end users
The global blood group typing market is analyzed across North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa).
Related Reports :-
https://www.kdmarketinsights.com/reports/diabetic-neuropathy-market/7166
https://www.kdmarketinsights.com/reports/dyspepsia-treatment-market/7165
https://www.kdmarketinsights.com/reports/autotransfusion-devices-market/7163
https://www.kdmarketinsights.com/reports/implantable-infusion-pump-market/7154
Key Insights of Neurotrophins Market
- On the basis of end user, the hospitals and clinics segment accounted for the largest market share in the blood group typing market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
- On the basis of region, North America accounted for the largest share in the global blood group typing market in 2022. The region is further projected to continue dominating in the market during the forecast period.
- On the basis of region, Europe is estimated to account for the second largest share in the market during the forecast period.
- Some of the major blood group typing companies profiled in the report include Quotient Limited, CareDx Inc., Agena Bioscience, Inc., DIAGAST, Illumina, Inc., Grifols, S.A., Immucor, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Merck KGaA, QIAGEN, Beckman Coulter, Inc., and QuidelOrtho Corporation.
